DSpace Repositorium (Manakin basiert)

Latin American consensus recommendations on the risk of infections in people with multiple sclerosis treated with disease modifying drugs

Zur Kurzanzeige

dc.contributor.author Silva, Berenice Anabel
dc.contributor.author Carnero Contentti, Edgar
dc.contributor.author Becker, Jefferson
dc.contributor.author Carranza, José I.
dc.contributor.author Correa Díaz, Edgar Patricio
dc.contributor.author Galleguillos Goiry, Lorna
dc.contributor.author Garcea, Orlando
dc.contributor.author Gracia, Fernando
dc.contributor.author Hamuy, Fernando
dc.contributor.author Macías, Miguel Angel
dc.contributor.author Navas, Carlos
dc.contributor.author Nuñez, Sebastián
dc.contributor.author Rojas, Juan Ignacio
dc.contributor.author Farez, Mauricio Franco
dc.contributor.author Alonso, Ricardo
dc.contributor.author López, Pablo Adrián
dc.date.accessioned 2024-02-07T17:15:43Z
dc.date.available 2024-02-07T17:15:43Z
dc.date.issued 2023-06-20
dc.identifier.citation Silva BA, Carnero Contentti E, Becker J, Carranza JI, Correa-Díaz PE, Galleguillos Goiry L, Garcea O, Gracia F, Hamuy F, Macías MA, Navas C, Nuñez S, Rojas JI, Farez MF, Alonso R, López P. Latin American consensus recommendations on the risk of infections in people with multiple sclerosis treated with disease modifying drugs. Mult Scler Relat Disord. 2023 Sep;77:104840. doi: 10.1016/j.msard.2023 es_ES
dc.identifier.uri https://doi.org/10.1016/j.msard.2023.104840
dc.identifier.uri https://repositorio.fleni.org.ar/xmlui/handle/123456789/975
dc.description.abstract Introduction: The emergence of several therapeutic options in multiple sclerosis (MS), which significantly modify the immune system functioning, has led to the need for the consideration of additional factors, such as risk of infections, in the decision-making process. The aim of these consensus recommendations was to discuss and perform a practical guide to Latin American neurologists on the risk of infections at diagnosis, follow-up and prior to initiation of DMDs. Methods: A panel of Latin American neurologists, experts in demyelinating diseases and dedicated to management and care of MS patients, gathered during 2021 and 2022 to make consensus recommendations on the risk of infections in PwMS treated with DMDs in Latin America. The RAND/UCLA methodology was developed to synthesize the scientific evidence and expert opinions on health care topics and was used for reaching a formal agreement. Results: Recommendations were established based on relevant published evidence and expert opinion, focusing on: 1- baseline infection disease and vaccination status; 2- opportunistic infections; 3- progressive multifocal leukoencephalopathy; 4- genitourinary system infections; 5- respiratory tract infections; 6- digestive system infections, 7-others local infections and 8- COVID-19. Conclusion: The recommendations of this consensus seek to optimize the care, management and treatment of PwMS in Latin America. The standardized evidence-based care of pwMS infections will allow better outcomes. es_ES
dc.language.iso eng es_ES
dc.publisher Elsevier es_ES
dc.subject COVID-19 es_ES
dc.subject Latin America es_ES
dc.subject América Latina es_ES
dc.subject Multiple Sclerosis es_ES
dc.subject Esclerosis Múltiple es_ES
dc.title Latin American consensus recommendations on the risk of infections in people with multiple sclerosis treated with disease modifying drugs es_ES
dc.type info:eu-repo/semantics/article es_ES
dc.description.fil Fil: Farez, Mauricio Franco. Fleni. Centro para la Investigación de Enfermedades Neuroinmunológicas; Argentina.
dc.relation.ispartofVOLUME 77
dc.relation.ispartofCOUNTRY Países Bajos
dc.relation.ispartofCITY Amsterdam
dc.relation.ispartofTITLE Multiple sclerosis and related disorders
dc.relation.ispartofISSN 2211-0356
dc.type.snrd info:ar-repo/semantics/artículo es_ES


Dateien zu dieser Ressource

Das Dokument erscheint in:

Zur Kurzanzeige

DSpace Suche


Stöbern

Mein Benutzerkonto

Statistik